Therapeutic options in advanced laryngeal cancer: An overview

ORL

Volumn 67, Issue 6, 2005, Pages 311-318

  Dias, Fernando L ^a   Lima, Roberto A ^a   Kligerman, Jacob ^a   Cernea, Claudio R ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; Larynx; Radiotherapy; Surgery; Treatment

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ANATOMY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LARYNGECTOMY; LARYNX CANCER; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION;

ANTINEOPLASTIC AGENTS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 30644466609     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090040     Document Type: Review

References (66)

1. Kirchner JA: Growth and spread of laryngeal cancer as related to partial laryngectomy. Laryngoscope 1975;85:1516-1521.
2. Kirchner JA: Glottic-supraglottic barrier: Fact or fantasy? Ann Otol Rhinol Laryngol 1997;106:700-704.
3. Myers EN, Alvi A: Management of carcinoma of the supraglottic larynx: Evolution, current concepts, and future trends. Laryngoscope 1996;106:559-567.
4. Tucker GF, Smith HR: A histological demonstration of the development of laryngeal connective tissue compartments. Trans Am Acad Ophthalmol Otolaryngol 1982;66:308-318.
5. Coutard H, Valat A: Considerations sur le cancer de la bande et la cavite ventriculaire du larynx. Ann d mal de l'oreille de larynx 1927;2:469-512.
6. Bocca E, Pignataro O, Mosciaro O: Supraglottic surgery of the larynx. Ann Otol Rhinol Laryngol 1968;77:1005-1026.
7. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ: Radiotherapy for carcinoma of the supraglottis. Otolaryngol Clin North Am 1997;30:145-161.
8. Harwood AR, Hill RP: Supraglottic laryngeal carcinoma. Int J Radiat Oncol Biol Phys 1983;9:1759-1760.
9. Mendenhall WM, Parsons JT, Mancuso AA, et al: Radiation therapy for squamous cell carcinoma of the supraglottic larynx: An alternative to surgery. Head Neck 1996;18:24-35.
10. Daugaard BJ, Sand HH: Primary radiotherapy of carcinoma of the supraglottic larynx - A multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1998;41:355-360.
11. Santos CR, Kowalski LP, Magrin J, et al: Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol 1998;107:697-702.
12. Sykes AJ, Slevin NJ, Gupta NK, Brewster AE: 331 cases of clinically node-negative supraglottic carcinoma of the larynx: A study of a modest size fixed radiotherapy approach. Int J Radiat Oncol Biol Phys 2000;46:1109-1115.
13. Hinerman RW, Mendenhall WM, Amdur RJ, et al: Carcinoma of the supraglottic larynx: Treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002;24:456-467.
14. Strong MS, Jako GJ: Laser surgery in the larynx. Early clinical experience with continuous CO2 laser. Ann Otol Rhinol Laryngol 1972;81:791-798.
15. 2 laser. Laryngoscope 1983;93:429-432.
16. Steiner W: Experience in endoscopie laser surgery of malignant tumours of the upper aero-digestive tract. Adv Otorhinolaryngol 1988;39:135-144.
17. Zeitels SM, Koufman JA, Davis RK, Vaughan CW: Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope 1994;104:71-78.
18. 2 laser excisional biopsy of early supraglottic cancer. Laryngoscope 1991:101:680-683.
19. Steiner W: Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116-121.
20. Rudert HH, Werner JA, Hoft S: Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 1999;108:819-827.
21. Alonso JM: Conservative surgery of cancer of the larynx. Trans Am Acad Ophthalmol Otolaryngol 1947;51:633-642.
22. Ogura JH, Sessions DG, Spector GJ: Conservation surgery for epidermoid carcinoma of the supraglottic larynx. Laryngoscope 1975;85:1808-1815.
23. Som ML: Conservation surgery for carcinoma of the supraglottis. J Laryngol Otol 1970;84:655-678.
24. Ogura JH, Marks JE, Freeman RB: Results of conservation surgery for cancers of supraglottis and pyriform sinus. Laryngoscope 1980;90:591-600.
25. Ogura JH, Dedo HH: Glottic reconstruction following subtotal glottic-supraglottic laryngectomy. Laryngoscope 1965;75:865-876.
26. Bocca E, Pignataro O, Oldini C: Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol 1983;92:14-18.
27. Burstein FD, Calcaterra TC: Supraglottic laryngectomy: Series report and analysis of results. Laryngoscope 1985;95:833-836.
28. Lee NK, Goepfert H, Wendt CD: Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope 1990;100:831-836.
29. Isaacs JH, Slattery WH, Mendenhall WM, Cassisi NJ: Supraglottic laryngectomy. Am J Otolaryngol 1998;19:118-123.
30. Scola B, Fernandez-Vega M, Martinez T, et al: Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001;124:195-198.
31. Majer H, Rieder A: Technique de la laryngectomie permetant de conserver la perméabilité respiratoire: La cricohyoidopexie. Ann Otolaryngol Chir Cervicofac 1959;76:677-683.
32. Piquet JJ, Desaulty A, Decroix G: La Cricohyoido-epiglotto-pexie. Technique opératoire et résultats fonctionnels. Ann Otolaryngol Chir Cervicofac 1974;91:681-690.
33. Laccourreye H, Laccourreye O, Weinstein G, Menard M, Brasnu D: Supracricoid laryngectomy with cricohyoidopexy: A partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 1990;100:735-741.
34. Chevalier D, Piquet JJ: Subtotal laryngectomy with cricohyoidopexy for supraglottic carcinoma: Review of 61 cases. Am J Surg 1994;168:472-473.
35. Naudo P, Laccourreye O, Weinstein G, et al: Functional outcome and prognostic factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol 1997;106:291-296.
36. de Vicentiis M, Minni A, Gallo A, Di Nardo A: Supracricoid partial laryngectomies: Oncologic and functional results. Head Neck 1998;20:504-509.
37. Laccourreye O, Brasnu D, Biacabe B, et al: Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 1998;20:595-599.
38. Schwaab G, Kolb F, Julieron M, et al: Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Goustave-Roussy experience (146 cases, 1974-1997). Eur Arch Otorinolaryngol 2001;258:246-249.
39. Mendenhall WM, Parsons JT, Stringer SP, et al: Stage T3 squamous cell carcinoma of the glottic larynx: A comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 1992;23:725-732.
40. Bryant GP, Poulsen MG, Tripcony L, et al: Treatment decisions in T3N0M0 glottic carcinoma. Int J Radiat Oncol Biol Phys 1995;31:285-293.
41. Harwood AR, Hawkins NV, Beale FA, et al: Management of advanced glottic cancer: A 10-year review of the Toronto experience. Int J Radiat Oncol Biol Phys 1979;5:899-904.
42. Wang CC: Radiation therapy of laryngeal tumors; in Thawley SE, Panje WR (eds): Comprehensive Management of Head and Neck Tumors. Philadelphia, WB Saunders, 1987.
43. Lima RA, Freitas EQ, Kligerman J, et al: Laringectomia Supracricóide (CHEP) para Câncer Glótico. Rev Col Bras Cir 2001;28:254-258.
44. Kessler DJ, Trapp TK, Calcaterra TC: The treatment of T3 glottic carcinoma with vertical partial laryngectomy. Arch Otolaryngol Head Neck Surg 1987;113:1196-1199.
45. Robson NL, Oswal VH, Flood LM: Radiation therapy of laryngeal cancer: A twenty year experience. J Laryngol Otol 1990;104:699-703.
46. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR: Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience. Head Neck 1993;15:87-96.
47. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ: Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997;106:364-369.
48. Pearson BW, Woods RD, Hartman DE: Extended hemilaryngectomy for T3 glottic carcinoma with preservation of speech and swallowing. Laryngoscope 1980;90:1950-1954.
49. Levine PA, Debo RF, Reibel JF: Pearson near-total laryngectomy: A reproducible speaking shunt. Head Neck 1994;16:323-325.
50. Shenoy AM, Plinkert PK, Nanjundappa N, et al: Functional utility and oncologic safety of near-total laryngectomy with tracheopharyngeal speech shunt in a third world oncologic center. Eur Arch Otorhinolaryngol 1997;254:128-132.
51. Pearson BW, DeSanto LW, Olsen KD, Salassa JR: Results in near-total laryngectomy. Ann Otol Rhinol Laryngol 1998;107:820-825.
52. Pradhan SA, D'Cruz AK, Pai PS, Mohiyuddin A: Near-total laryngectomy in advanced laryngeal and pyriform cancers. Laryngoscope 2002;112:375-380.
53. Bernaldez R, Garcia-Pallares M, Morera E, et al: Oncologic and functional results of near-total laryngectomy. Otolaryngol Head Neck Surg 2003;128:700-705.
54. Robbins KT, Michaels L: Feasibility of subtotal laryngectomy based on whole-organ examination. Arch Otolaryngol 1985;111:356-360.
55. Lima RA, Freitas EQ, Kligerman J, et al: Near-total laryngectomy for treatment of advanced laryngeal cancer. Am J Surg 1997;174:490-491.
56. Yuen A, Medina JE, Goepfert H, Fletcher GH: Management of stage T3 and T4 glottic carcinomas. Am J Surg 1984;148:467-472.
57. DeSanto LW: T3 glottic cancer: Options and consequences of the options. Laryngoscope 1984;94:1311-1315.
58. Razack MS, Maipang T, Sako K, et al: Management of advanced glottic carcinomas. Am J Surg 1989;158:318-320.
59. Dias FL, Kligerman J, Lima RA, et al: Prognostic significance of cartilage invasion in surgically treated advanced laryngeal cancer (abstract). Final Program and Abstract Book - 5th International Conference on Head and Neck Cancer 1, 2000.
60. Hong WK, O'Donoghue GM, Sheetz S, et al: Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: Potential impact of treatment in advanced laryngeal cancer. Prog Clin Biol Res 1985;201:191-197.
61. Pfister DG, Strong E, Harrison L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991;9:850-859.
62. Wolf GT, Hong WK, Fisher SG, et al: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
63. El Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14:838-847.
64. Lefebvre JL, Wolf G, Luboinski B: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (2) larynx preservation using neoadjuvant chemotherapy (CT) in laryngeal and hypopharyngeal carcinoma. Proc ASCO 1473, 1998.
65. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
66. Weinstein GS, Myers EN, Shapshay SM: Non-surgical treatment of laryngeal cancer. N Engl J Med 2004;350:1049-1053.